New drug combo aims to control Hard-to-Treat hepatitis d
NCT ID NCT05461170
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 36 times
Summary
This phase 2 study tests two experimental drugs, VIR-2218 and VIR-3434, in about 95 adults with chronic hepatitis D. The goal is to see if the drugs can lower the virus level and improve liver health. Participants must have had hepatitis D for at least 6 months and be on certain other liver medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS D, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site
Sofia, 1407, Bulgaria
-
Investigative Site
Sofia, 1431, Bulgaria
-
Investigative Site
Stara Zagora, 6003, Bulgaria
-
Investigative Site
Clichy, 92110, France
-
Investigative Site
Pessac, 33600, France
-
Investigative Site
Rennes, 35000, France
-
Investigative Site
Toulouse, 31000, France
-
Investigative Site
Frankfurt, 60596, Germany
-
Investigative Site
Hanover, 30625, Germany
-
Investigative Site
Tübingen, 72076, Germany
-
Investigative Site
Milan, 20122, Italy
-
Investigative Site
Pisa, 56124, Italy
-
Investigative Site
Chisinau, MD-2025, Moldova
-
Investigative Site
Rotterdam, 3015 GD, Netherlands
-
Investigative Site
Auckland, 1010, New Zealand
-
Investigative Site
Bucharest, 021105, Romania
-
Investigative Site
Birmingham, B15 2TT, United Kingdom
-
Investigative Site
London, E1 1RF, United Kingdom
-
Investigative Site
London, SE5 9RS, United Kingdom
-
Investigative Site
Manchester, M8 5RB, United Kingdom
Conditions
Explore the condition pages connected to this study.